PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Progyny, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$27.84+0.98 (+3.65%)
Close on Oct 19, 2026
- Market cap
- $2.29B
- P/E (TTM)
- 30.3
- Dividend yield
- –
Progyny, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Fertility benefits services revenue | $830.93M | $729.55M | $676.30M | $510.15M | $355.62M | $253.56M | $189.62M | $99.79M | 64.5% | +13.9% |
| Pharmacy benefits services revenue | $457.73M | $437.67M | $412.30M | $276.77M | $145.01M | $91.30M | $40.07M | $5.61M | 35.5% | +4.6% |
By region
From the segment and revenue-disaggregation notes of Progyny's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.